Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based provider of drug discovery services to the pharmaceutical, biotech, diagnostics and materials sciences.
As a company, we have a single aim: to accelerate our customers’ discovery initiatives through innovation.
By applying our renowned skills for problem-solving, and open communications, Peakdale scientists pride themselves in seizing the initiative, providing energy, skill and creativity toward the project objectives.
Peakdale Molecular operates on two sites, from our headquarters in the Peak District and at Discovery Park located at Sandwich, Kent.
Our range of speciality services includes:
Drug Discovery Support, Nucleoside Chemistry, Materials Chemistry and Research Support.
In Vitro ADMET, Medicinal Chemistry, Computational Chemistry Services
We place great emphasis on the close interaction between our medicinal chemists, our Computational Chemistry department, our Synthetic Chemistry, and our in vitro ADMET department.
Nucleoside, Nucleotide and Carbohydrate Chemistry.
Peakdale Molecular has particular expertise in the specialist chemistry, purification and analytical techniques required to synthesise these challenging compounds.
Printable Electronics, Nanomaterials, Performance Lubricants & Fuel Additives
In recent years, Peakdale Molecular has rapidly developed experience and expertise in synthetic chemistry for high value materials, and has invested in state-of-the-art equipment to enable materials science projects.
PR&D, Analytical & Purification, Pressure & Hydrogenation Chemistry, Catalogue
Peakdale is able to fully support your research program with experienced scientists and specialist services. All services are available individually (on a Fee For Service basis) or as part of a fully integrated research project (utilising dedicated Full-Time Equivalent scientists).
Customised Assay Design, Highly Repoducible Data and Direct Communications.
At Peakdale Molecular our range of in vitro ADMET models delivers high quality, accurate and reproducible data. With efficient turnaround times, we help accelerate our customers’ drug discovery programmes. In addition to our core assays, we offer clients the option of customised assay design within a completely confidential service.
Concept Life Sciences Groups Expands Its Services to the US
The Concept Life Sciences Group, a group created following the acquisition of Peakdale Molecular Limited, Scientific Analysis Laboratories Limited and Resource & Environmental Consultants Limited, has launched its services in the US. The integrated group, which further expanded following the acquisition of CXR Biosciences and Agenda1 Analytical Services in 2015, offers a comprehensive range of […]
2016 FCG Postgraduate Event Scotland
The Scotland section meeting of the annual SCI Postgraduate Symposium took place at the University of St. Andrews on Tuesday 12 April 2016. An audience of over 70 attended the meeting and they were treated to ten talks by speakers from five universities; Edinburgh, Heriot-Watt, Glasgow, Strathclyde and St. Andrews. The talks contained science […]
Concept Life Sciences Group Event Success: Early Safety and Enhancing the Discovery Process Spotlight, London, UK
Peakdale Molecular and CXR Biosciences (members of the Concept Life Sciences Group) brought together a number of eminent speakers recently as part of their Spotlight Session series. The event, which was held at the Kohn Centre at the Royal Society in London focussed on current challenges in integrating safety testing into early drug, agrochemical and […]
Peakdale Hosts ECHONET Training Day
On Friday 15th April Peakdale will host the next ECHONET training day at their Chapel-en-le-Frith Headquarters. During this 1 day event, Peakdale will host a number of workshop classes, geared towards medicinal chemistry. A mixture of hands-on modules and theoretical seminars will give researchers attending the day an introduction to the basic aspects and current developments in medicinal chemistry. […]
Peakdale host: 4th SYNTHESIS IN DRUG DISCOVERY AND DEVELOPMENT symposium
SYNTHESIS IN DRUG DISCOVERY AND DEVELOPMENT 4TH SYMPOSIUM Following on from our hugely successful first symposium in Manchester (2010), symposium in Sheffield (2012) and Leeds (2014) we are pleased to announce the details of our 4th ‘Synthesis in Drug Discovery and Development’ Symposium. TUESDAY 18TH OCTOBER 2016 – THE EDEN BUILDING, LIVERPOOL HOPE UNIVERSITY Following on […]
Spotlight Session 2016: Enhancing the Drug Discovery Process
Alongside CXR Biosciences we are proud to present our first joint Spotlight Session. Peakdale Molecular & CXR Biosciences of the Concept Life Sciences Group present their Annual Academic Spotlight Session in the prestigious settings of the Kohn Centre at The Royal Society, London. This event will involve roundtable discussion, bringing together influential members from across […]
Peakdale Molecular reinforces its commitment to science and extends its Discovery Park lease by a further decade
Peakdale Molecular, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries has extended its Discovery Park lease for a further ten years.